AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,661 | -43.2% | 4,659 | -58.3% | 0.00% | 0.0% |
Q2 2023 | $34,611 | +494342.9% | 11,165 | +120.0% | 0.00% | – |
Q1 2023 | $7 | -58.8% | 5,076 | -39.9% | 0.00% | -100.0% |
Q4 2022 | $17 | -99.9% | 8,439 | +14.6% | 0.00% | – |
Q3 2022 | $15,000 | -31.8% | 7,362 | +7.0% | 0.00% | – |
Q2 2022 | $22,000 | +144.4% | 6,878 | +192.8% | 0.00% | – |
Q1 2022 | $9,000 | -30.8% | 2,349 | -10.5% | 0.00% | – |
Q4 2021 | $13,000 | -75.9% | 2,624 | -74.1% | 0.00% | -100.0% |
Q3 2021 | $54,000 | -30.8% | 10,115 | -33.2% | 0.00% | -50.0% |
Q2 2021 | $78,000 | +16.4% | 15,143 | +52.1% | 0.00% | +100.0% |
Q1 2021 | $67,000 | -65.6% | 9,959 | -76.7% | 0.00% | -83.3% |
Q4 2020 | $195,000 | -63.9% | 42,670 | -69.4% | 0.01% | 0.0% |
Q3 2020 | $540,000 | +223.4% | 139,332 | +296.6% | 0.01% | -14.3% |
Q2 2020 | $167,000 | +943.8% | 35,129 | +549.0% | 0.01% | +600.0% |
Q3 2019 | $16,000 | -71.4% | 5,413 | -30.3% | 0.00% | -75.0% |
Q2 2019 | $56,000 | +366.7% | 7,766 | +790.6% | 0.00% | +300.0% |
Q1 2019 | $12,000 | -47.8% | 872 | -48.7% | 0.00% | -50.0% |
Q4 2018 | $23,000 | – | 1,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $144,839,000 | 11.40% |
Eversept Partners, LP | 4,755,480 | $32,004,380 | 2.41% |
TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $109,116,000 | 1.27% |
EAM Global Investors LLC | 365,719 | $2,461,000 | 0.68% |
Signature Wealth Management Partners, LLC | 87,666 | $590,000 | 0.57% |
Jackson Creek Investment Advisors LLC | 221,043 | $1,488,000 | 0.52% |
Tranquilli Financial Advisor LLC | 71,414 | $481,000 | 0.39% |
Hillsdale Investment Management Inc. | 611,200 | $4,113,000 | 0.34% |
EAM Investors, LLC | 259,873 | $1,749,000 | 0.26% |
HUSSMAN STRATEGIC ADVISORS, INC. | 180,000 | $1,211,000 | 0.25% |